These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25963555)

  • 1. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
    Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M
    Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian and cervical cancer patient derived xenografts: The past, present, and future.
    Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
    Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors.
    Bondarenko G; Ugolkov A; Rohan S; Kulesza P; Dubrovskyi O; Gursel D; Mathews J; O'Halloran TV; Wei JJ; Mazar AP
    Neoplasia; 2015 Sep; 17(9):735-741. PubMed ID: 26476081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
    Jäger W; Xue H; Hayashi T; Janssen C; Awrey S; Wyatt AW; Anderson S; Moskalev I; Haegert A; Alshalalfa M; Erho N; Davicioni E; Fazli L; Li E; Collins C; Wang Y; Black PC
    Oncotarget; 2015 Aug; 6(25):21522-32. PubMed ID: 26041878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine.
    Okada S; Vaeteewoottacharn K; Kariya R
    Chem Pharm Bull (Tokyo); 2018; 66(3):225-230. PubMed ID: 29491256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
    Vaeteewoottacharn K; Pairojkul C; Kariya R; Muisuk K; Imtawil K; Chamgramol Y; Bhudhisawasdi V; Khuntikeo N; Pugkhem A; Saeseow OT; Silsirivanit A; Wongkham C; Wongkham S; Okada S
    Cells; 2019 May; 8(5):. PubMed ID: 31126020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
    Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
    J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of human tumor xenografts in immunodeficient mice.
    Morton CL; Houghton PJ
    Nat Protoc; 2007; 2(2):247-50. PubMed ID: 17406581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
    Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
    Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.
    Ilie M; Nunes M; Blot L; Hofman V; Long-Mira E; Butori C; Selva E; Merino-Trigo A; Vénissac N; Mouroux J; Vrignaud P; Hofman P
    Cancer Med; 2015 Feb; 4(2):201-11. PubMed ID: 25470237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of transcriptome in cancer patient-derived xenografts.
    Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y
    PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.
    Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J
    Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.
    Xu W; Zhao ZY; An QM; Dong B; Lv A; Li CP; Guan XY; Tian XY; Wu JH; Hao CY
    Int J Med Sci; 2020; 17(18):3073-3081. PubMed ID: 33173428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeutics.
    Yan J; Wu X; Yu J; Ma M; Yu H; Xu T; Tang H; Xu L; Dai J; Si L; Chi Z; Sheng X; Cui C; Guo J; Kong Y
    Melanoma Res; 2018 Dec; 28(6):527-535. PubMed ID: 30086074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and preclinical application of a patient-derived xenograft model for uterine cancer.
    Jeong SY; Cho YJ; Ryu JY; Choi JJ; Hwang JR; Kim B; Lee YY; Kim HS; Lee JW
    Gynecol Oncol; 2021 Jul; 162(1):173-181. PubMed ID: 33972086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
    Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
    Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation of PDX-Bearing Humanized Mice to Study Immuno-oncology.
    Yao LC; Aryee KE; Cheng M; Kaur P; Keck JG; Brehm MA
    Methods Mol Biol; 2019; 1953():241-252. PubMed ID: 30912026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Establishment of Robustness and Standards in Patient-Derived Xenograft Experiments and Analysis.
    Evrard YA; Srivastava A; Randjelovic J; Doroshow JH; Dean DA; Morris JS; Chuang JH;
    Cancer Res; 2020 Jun; 80(11):2286-2297. PubMed ID: 32152150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.